CIBC Asset Management
TXG icon

CIBC Asset Management’s 10x Genomics TXG Stock Holding History

CIBC Asset Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15,938
Closed -$360K – 1296
2024
Q3 		$360K Sell
15,938
-79,321
-83% -$1.64M ﹤0.01% 819
2024
Q2 		$1.85M Buy
95,259
+23,112
+32% +$605K 0.01% 564
2024
Q1 		$2.71M Buy
+72,147
New +$3.17M 0.01% 505
2023
Q2 		– Sell
-160,750
Closed -$8.97M – 1117
2023
Q1 		$8.97M Sell
160,750
-128,394
-44% -$6M 0.04% 262
2022
Q4 		$10.5M Sell
289,144
-46,262
-14% -$1.51M 0.04% 225
2022
Q3 		$9.55M Buy
+335,406
New +$12.8M 0.04% 226
2022
Q2 		– Sell
-4,530
Closed -$345K – 1473
2022
Q1 		$345K Hold
4,530
– – ﹤0.01% 976
2021
Q4 		$675K Buy
4,530
+114
+3% +$17.5K ﹤0.01% 776
2021
Q3 		$643K Buy
4,416
+441
+11% +$75.7K ﹤0.01% 770
2021
Q2 		$778K Hold
3,975
– – ﹤0.01% 730
2021
Q1 		$719K Buy
3,975
+463
+13% +$80K ﹤0.01% 725
2020
Q4 		$497K Hold
3,512
– – ﹤0.01% 751
2020
Q3 		$438K Buy
3,512
+87
+3% +$9.13K ﹤0.01% 731
2020
Q2 		$306K Hold
3,425
– – ﹤0.01% 793
2020
Q1 		$213K Hold
3,425
– – ﹤0.01% 850
2019
Q4 		$261K Buy
+3,425
New +$206K ﹤0.01% 932

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CIBC Asset Management's TXG Position: Q4 2024 in Review

CIBC Asset Management sold out of 10x Genomics (TXG) in Q4 2024, closing a stake of 15,938 shares — an estimated $360K sold.

CIBC Asset Management first reported a position in TXG in Q4 2019 and held it in 16 quarters. The position peaked at $10.5M in Q4 2022. 273 funds tracked by Wall St. Rank hold TXG as of Q4 2024.

  • CIBC Asset Management reported no remaining 10x Genomics position as of Q4 2024 after selling out during the quarter.
  • CIBC Asset Management sold 15,938 10x Genomics shares in Q4 2024, an estimated $360K.
  • CIBC Asset Management first reported a position in 10x Genomics in Q4 2019 and held it in 16 quarters.
  • CIBC Asset Management's 10x Genomics position peaked at $10.5M in Q4 2022.
  • 273 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2024.

Based on CIBC Asset Management's 13F filing for Q4 2024, filed 31 Jan 2025.